A detailed history of Clark Estates Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Clark Estates Inc holds 42,000 shares of LNTH stock, worth $2.23 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
42,000
Holding current value
$2.23 Million
% of portfolio
0.65%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$50.11 - $83.83 $2.1 Million - $3.52 Million
42,000 New
42,000 $2.15 Million
Q1 2025

May 08, 2025

SELL
$78.23 - $110.01 $753,902 - $1.06 Million
-9,637 Reduced 27.63%
25,237 $2.46 Million
Q4 2024

Feb 06, 2025

SELL
$76.22 - $116.71 $322,105 - $493,216
-4,226 Reduced 10.81%
34,874 $3.12 Million
Q3 2024

Nov 13, 2024

SELL
$77.7 - $123.62 $637,140 - $1.01 Million
-8,200 Reduced 17.34%
39,100 $4.29 Million
Q2 2024

Aug 08, 2024

BUY
$58.87 - $83.05 $2.78 Million - $3.93 Million
47,300 New
47,300 $3.8 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $3.64B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Clark Estates Inc Portfolio

Follow Clark Estates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark Estates Inc with notifications on news.